- Japan
- /
- Specialty Stores
- /
- TSE:3172
Tea Life First Quarter 2025 Earnings: EPS: JP¥7.98 (vs JP¥4.93 in 1Q 2024)
Tea Life (TSE:3172) First Quarter 2025 Results
Key Financial Results
- Revenue: JP¥2.68b (down 12% from 1Q 2024).
- Net income: JP¥34.0m (up 62% from 1Q 2024).
- Profit margin: 1.3% (up from 0.7% in 1Q 2024). The increase in margin was driven by lower expenses.
- EPS: JP¥7.98 (up from JP¥4.93 in 1Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Tea Life shares are down 2.3% from a week ago.
Risk Analysis
It's necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with Tea Life (at least 1 which shouldn't be ignored), and understanding them should be part of your investment process.
Valuation is complex, but we're here to simplify it.
Discover if Tea Life might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:3172
Tea Life
Engages in the Internet and catalog sale of health tea, health foods, cosmetics, medicines, etc.
Flawless balance sheet average dividend payer.